In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping

Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review

(2021) Simge Acar et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Development and validation of a fast ultra high‐performance liquid chromatography tandem mass spectrometry (UHPLC‐MS/MS) method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair

(2021) Alfredo Fabrizio Lo Faro et al.   Drug Testing and Analysis

Hair testing for acetazolamide as an evidence of the use of a contaminated dietary supplement

(2021) Pascal Kintz et al.   Drug Testing and Analysis

Characterization of Cytosolic Glutathione S-Transferases Involved in the Metabolism of the Aromatase Inhibitor, Exemestane

(2021) Irina Teslenko et al.   DRUG METABOLISM AND DISPOSITION

In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites

(2021) Annagiulia Di Trana et al.   TALANTA

Identification of Trenbolone Metabolites Using Hydrogen Isotope Ratio Mass Spectrometry and Liquid Chromatography/High Accuracy/High Resolution Mass Spectrometry for Doping Control Analysis

(2020) Marlen Putz et al.   Frontiers in Chemistry

GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics

(2020) Christina de Bruyn Kops et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence

(2020) Aidan J. Hampson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry

(2018) Xingxing Diao et al.   Forensic Toxicology

Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection

(2018) Jeremy Carlier et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Altitude sickness and acetazolamide

(2018) Jonathan Williamson et al.   BMJ-British Medical Journal

Altitude sickness and acetazolamide

(2018) Jonathan Williamson et al.   BMJ-British Medical Journal

Review of the Diagnosis and Treatment of Periodic Paralysis

(2017) Jeffrey M. Statland et al.   MUSCLE & NERVE

In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201)

(2016) Xingxing Diao et al.   Forensic Toxicology

A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials

(2016) Aidan J. Hampson et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant

(2016) Madeleine J Swortwood et al.   Bioanalysis

Acetazolamide for the treatment of idiopathic intracranial hypertension

(2015) Claudiu T Supuran   Expert Review of Neurotherapeutics

Acetazolamide for the treatment of idiopathic intracranial hypertension

(2015) Claudiu T Supuran   Expert Review of Neurotherapeutics

Current applications of high-resolution mass spectrometry in drug metabolism studies

(2012) Markus R. Meyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis

(2010) Amy B Cadwallader et al.   BRITISH JOURNAL OF PHARMACOLOGY

Interferences and contaminants encountered in modern mass spectrometry

(2008) Bernd O. Keller et al.   ANALYTICA CHIMICA ACTA

Identification and determination of metabolites and degradation products of sulfonamide antibiotics

(2008) Mª Jesús García-Galán et al.   TRAC-TRENDS IN ANALYTICAL CHEMISTRY